ProQR Announces Positive Top-Line Results from a Phase 1b Study of QR-010 in Subjects with Cystic Fibrosis Press release … intends to target these mutations using its proprietary Axiomer ® technology, which has shown compelling data in … September 25, 2017
ProQR Reports Fourth Quarter and Full Year 2018 Operating and Financial Results Press release … develop any new product candidates, including through our Axiomer ® platform, that prior results observed from … Februar 27, 2019